Skip to main content
. 2021 Aug 20;13(8):2857. doi: 10.3390/nu13082857

Table 1.

Baseline characteristics of the Epirus Health Study participants overall and according to sex.

Total (n = 1237) Women (n = 748) Men (n = 489) p-Value
Demographics
Age (years) 48.1 (11.0) 48.2 (10.8) 48.0 (11.5) 0.79
Education (years)
≤12 408 (33.0) 241 (32.3) 167 (34.2)
>12 827 (67.0) 505 (67.7) 322 (65.8) 0.50
Employment status
Employed 927 (75.3) 538 (72.3) 389 (79.9)
Other 304 (24.7) 206 (27.7) 98 (20.1) 2.6−03
After-tax income (€/month)
≤500 151 (13.1) 117 (16.8) 34 (7.5)
501–900 298 (25.9) 205 (29.4) 93 (20.5)
901–1400 515 (44.7) 306 (43.9) 209 (46.0)
>1400 187 (16.2) 69 (9.9) 118 (26.0) 3.1−15
Lifestyle
PSQI 4.9 (2.5) 5.1 (2.7) 4.5 (2.1) 2.7−06
MEDAS 7.2 (1.8) 7.4 (1.7) 7.1 (1.8) 3.2−03
Physical activity (MET-hours/week) 15.3 (20.1) 13.6 (18.8) 18.0 (21.7) 1.9−04
Smoking status
Never smokers 423 (34.2) 278 (37.2) 145 (29.7)
Former smokers 431 (34.9) 234 (31.3) 197 (40.3)
Current smokers 382 (30.9) 235 (31.5) 147 (30.1) 2.6−03
Alcohol consumption
Never 151 (12.2) 114 (15.3) 37 (7.6)
Less than once/month 362 (29.3) 261 (34.9) 101 (20.7)
1–3 times/month 211 (17.1) 125 (16.7) 86 (17.6)
1–2 times/week 342 (27.7) 180 (24.1) 162 (33.1)
At least 3 times/week 170 (13.8) 67 (9.0) 103 (21.1) 1.8−15
Cellphone use at least once/week (years)
≤10 81 (6.6) 64 (8.6) 17 (3.5)
11–15 149 (12.1) 101 (13.5) 48 (9.8)
16–20 273 (22.1) 162 (21.7) 111 (22.7)
>20 733 (59.3) 420 (56.2) 313 (64.0) 4.0−04
Dietary supplement use during last week 384 (31.4) 276 (37.3) 108 (22.4) 4.2−08
Personal medical history (self-reported)
General health status
Very good 460 (37.2) 256 (34.3) 204 (41.7)
Good 626 (50.7) 390 (52.3) 236 (48.3)
Moderate/Bad/Very bad 149 (12.1) 100 (13.4) 49 (10.0) 0.02
Chronic health condition 507 (41.2) 338 (45.4) 169 (34.8) 2.5−04
Limitation of usual activities during last year because of a health issue 191 (15.5) 124 (16.6) 67 (13.7) 0.17
Symptoms of stress during last 2 weeks 44 (3.6) 37 (5.0) 7 (1.4) 1.1−03
Symptoms of depression during last 2 weeks 38 (3.1) 31 (4.1) 7 (1.4) 0.01
Diabetes mellitus diagnosis 62 (5.0) 43 (5.8) 19 (3.9) 0.14
High cholesterol diagnosis 326 (26.5) 201 (26.9) 125 (25.7) 0.63
High blood pressure diagnosis 168 (13.6) 80 (10.7) 88 (18.0) 2.5−04
Bleeding gums 424 (34.3) 268 (35.9) 156 (31.9) 0.15
Lost/removed teeth (excl. wisdom teeth) 743 (61.5) 453 (62.2) 290 (60.3) 0.50
No. of dental fillings 3.3 (3.7) 3.4 (3.9) 3.2 (3.4) 0.55
Hearing impairment 92 (7.4) 48 (6.4) 44 (9.0) 0.09
Weight change since last year
Same weight 650 (52.7) 363 (48.6) 287 (58.9)
Weight gain 381 (30.9) 271 (36.3) 110 (22.6)
Weight loss 203 (16.5) 113 (15.1) 90 (18.5) 2.4−06
Weight at 18 years (kg) 62.8 (12.5) 56.6 (8.6) 73.3 (10.9) 3.0−131
No. of drugs taken during last week
0 777 (63.4) 451 (60.8) 326 (67.5)
1 244 (19.9) 162 (21.8) 82 (17.0)
≥2 204 (16.7) 129 (17.4) 75 (15.5) 0.05
Clinical examinations
BMI (kg/m2) 26.5 (4.8) 25.7 (4.9) 27.7 (4.4) 2.6−12
Waist circumference (cm) 93.7 (13.8) 88.7 (12.6) 101.1 (12.1) 4.7−58
Hip circumference (cm) 101.9 (8.0) 102.0 (8.4) 101.6 (7.3) 0.35
Fat mass (%) 1 28.5 (7.7) 31.9 (6.9) 23.5 (5.9) 9.2−89
Fasting glucose (mg/dL) 86.3 (15.2) 84.3 (15.2) 89.4 (14.6) 9.3−09
Total cholesterol (mg/dL) 195.1 (34.2) 195.7 (33.6) 194.2 (35.3) 0.44
LDL cholesterol (mg/dL) 126.2 (34.0) 123.3 (33.8) 130.5 (33.9) 3.5−04
HDL cholesterol (mg/dL) 54.4 (12.4) 58.8 (12.1) 47.7 (9.5) 2.6−57
Triglycerides (mg/dL) 96.2 (57.7) 85.2 (50.3) 112.9 (63.8) 1.7−16
Systolic blood pressure (mmHg) 2 119.2 (13.4) 116.1 (13.1) 123.9 (12.5) 2.5−23
Diastolic blood pressure (mmHg) 2 77.6 (10.4) 75.1 (9.6) 81.5 (10.3) 1.4−26
Pulse wave velocity 2 6.9 (1.4) 6.8 (1.4) 7.1 (1.4) 1.1−03

Abbreviations: PSQI; Pittsburgh Sleep Quality Index, MEDAS; Mediterranean Diet Adherence Screener, MET; Metabolic Equivalent of Energy Expenditure, BMI; Body Mass Index, LDL; Low-density lipoprotein, HDL; High-density lipoprotein. Characteristics are presented as mean (standard deviation) for continuous variables and frequency (percentage) for categorical variables. Independent samples t-tests or chi-squared tests were used for comparing associations by sex. 1 Fat mass was measured using bioelectrical impedance analysis. 2 Systolic, diastolic blood pressure and pulse wave velocity were measured as average of three consecutive measurements with an arterial stiffness monitor.